Risk of keratinocyte carcinoma among patients with hidradenitis suppurativa
- 9 July 2020
- journal article
- letter
- Published by Oxford University Press (OUP) in British Journal of Dermatology
- Vol. 183 (5), 962-964
- https://doi.org/10.1111/bjd.19256
Abstract
No abstract availableFunding Information
- National Cancer Institute (R01 CA241623, R01 CA231264)
- National Institute of Arthritis and Musculoskeletal and Skin Diseases (K24 AR069760)
This publication has 9 references indexed in Scilit:
- Incidence, demographics and surgical outcomes of cutaneous squamous cell carcinoma diagnosed in Northland, New Zealand2018
- Cutaneous squamous cell carcinoma complicating hidradenitis suppurativa: a review of the prevalence, pathogenesis, and treatment of this dreaded complicationActa Dermatovenerologica Alpina Pannonica et Adriatica, 2018
- Major prognostic factors for recurrence and survival independent of the American Joint Committee on Cancer eighth edition staging system in patients with cutaneous squamous cell carcinoma treated with multimodality therapyHead & Neck, 2018
- Acne and hidradenitis suppurativaBritish Journal of Dermatology, 2018
- A systematic review and critical evaluation of reported pathogenic sequence variants in hidradenitis suppurativaBritish Journal of Dermatology, 2017
- Squamous cell carcinoma complicating a chronic lesion of hidradenitis suppurativa: a case report and review of the literatureInternational Wound Journal, 2016
- Clinicopathological Study of 13 Cases of Squamous Cell Carcinoma Complicating Hidradenitis SuppurativaDermatology, 2009
- Incidence of cancer among patients with hidradenitis suppurativa.2001